Tag Archives: Alzheon Inc.

Flood gates for medical IPO filings still wide open as Labor Day holiday only speeds up pace for hopefuls.

The somber mood of summer’s waning days and shortened work week didn’t cool the blistering pace of biotech and other healthcare IPO news. Almost makes me feel sorry for the… Read more »

Heath stock take it on the chin while immuno-oncology IPOs keep a coming.

1. Medical Stock Spotlight 1) Losers far outpaced winners last week with Edge Therapeutics Inc. (Nasdaq:EDGE) nosediving 93% over the week to $1.18. Up until last week, shares of Edge Thera… Read more »